E-LIB Suche - Ergebnisse für: Sarsons, Christopher D

1

#2999 APABETALONE REDUCES CARDIAC EVENTS IN CKD PATIENTS BY..:

Gilham, Dean ; Wasiak, Sylwia ; Rakai, Brooke...
Nephrology Dialysis Transplantation. 38 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

2

Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opp..:

Sarsons, Christopher D. ; Gilham, Dean ; Tsujikawa, Laura M....
Biomedicines. 11 (2023) 10 - p. 2683 , 2023

Link: https://doi.org/10.3390/..

3

Apabetalone Downregulates Fibrotic, Inflammatory and Calcif..:

Gilham, Dean ; Wasiak, Sylwia ; Rakai, Brooke D....
Biomedicines. 11 (2023) 6 - p. 1663 , 2023

Link: https://doi.org/10.3390/..

4

Dual mechanism: Epigenetic inhibitor apabetalone reduces SA..:

Fu, Li ; Gilham, Dean ; Stotz, Stephanie C....
International Immunopharmacology. 117 (2023) - p. 109929 , 2023

Link: https://doi.org/10.1016/..

5

Breaking boundaries: Pan BETi disrupt 3D chromatin structur..:

Tsujikawa, Laura M. ; Kharenko, Olesya A. ; Stotz, Stephanie C....
Biomedicine & Pharmacotherapy. 152 (2022) - p. 113230 , 2022

Link: https://doi.org/10.1016/..

6

MO072APABETALONE DOWNREGULATES FIBROTIC, INFLAMMATORY AND C..:

Gilham, Dean ; Fu, Li ; Rakai, Brooke...
Nephrology Dialysis Transplantation. 36 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

7

SO078APABETALONE, A BROMODOMAIN AND EXTRA-TERMINAL (BET) PR..:

Kulikowski, Ewelina ; Haarhaus, Mathias ; Kalantar-Zadeh, Kamyar...
Nephrology Dialysis Transplantation. 35 (2020) Supplement_3 - p. , 2020

Link: https://doi.org/10.1093/..

8

Apabetalone (RVX-208) reduces vascular inflammation in vitr..:

Tsujikawa, Laura M. ; Fu, Li ; Das, Shovon...
Clinical Epigenetics. 11 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

9

Apabetalone downregulates factors and pathways associated w..:

Gilham, Dean ; Tsujikawa, Laura M. ; Sarsons, Christopher D....
Atherosclerosis. 280 (2019) - p. 75-84 , 2019

Link: https://doi.org/10.1016/..

10

Surface-grafted polyethylene glycol conformation impacts th..:

Labouta, Hagar I. ; Gomez-Garcia, M. Juliana ; Sarsons, Christopher D....
RSC Advances. 8 (2018) 14 - p. 7697-7708 , 2018

Link: https://doi.org/10.1039/..

11

Understanding and improving assays for cytotoxicity of nano..:

Labouta, Hagar I. ; Sarsons, Christopher ; Kennard, Jacob...
RSC Advances. 8 (2018) 41 - p. 23027-23039 , 2018

Link: https://doi.org/10.1039/..

12

Quantum dot interactions and flow effects in angiogenic zeb..:

Jiang, Xiao-Yu ; Sarsons, Christopher D. ; Gomez-Garcia, M. Juliana...
Nanomedicine: Nanotechnology, Biology and Medicine. 13 (2017) 3 - p. 999-1010 , 2017

Link: https://doi.org/10.1016/..

13

Tailoring nanoparticle designs to target cancer based on tu..:

Sykes, Edward A. ; Dai, Qin ; Sarsons, Christopher D....
Proceedings of the National Academy of Sciences of the United States of America. 113 (2016) 9 - p. E1142-E1151 , 2016

Link: https://www.jstor.org/st..

14

Tailoring nanoparticle designs to target cancer based on tu..:

Sykes, Edward A. ; Dai, Qin ; Sarsons, Christopher D....
Proceedings of the National Academy of Sciences. 113 (2016) 9 - p. , 2016

Link: https://doi.org/10.1073/..

15

Maltol‐Functionalized Fe3O4 Nanoparticles as T2 Magnetic Re..:

Clements, Thomas W. ; Sarsons, Christopher ; Platnich, Casey M....
ChemistrySelect. 1 (2016) 8 - p. 1602-1606 , 2016

Link: https://doi.org/10.1002/..